{"id":9494,"date":"2012-06-29T00:00:00","date_gmt":"2012-06-28T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2012\/06\/29\/f-xavier-bosch-premi-fundacio-lilly-en-investigacio-preclinica\/"},"modified":"2022-06-15T10:16:54","modified_gmt":"2022-06-15T08:16:54","slug":"f-xavier-bosch-premi-fundacio-lilly-en-investigacio-preclinica","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2012\/06\/f-xavier-bosch-premi-fundacio-lilly-en-investigacio-preclinica\/","title":{"rendered":"F. Xavier Bosch, Premi Fundaci\u00f3 Lilly en Investigaci\u00f3 Precl\u00ednica"},"content":{"rendered":"

Acte de lliurament dels premis Fundaci\u00f3 Lilly d’Investigaci\u00f3 Biom\u00e8dica Xavier Bosch, investigador de l’IDIBELL a l’ICO i referent mundial en virus del papil\u00b7loma hum\u00e0 i c\u00e0ncer de c\u00e8rvix, ha rebut el premi 2012 de la Fundaci\u00f3 Lilly en reconeixement a la innovaci\u00f3 investigadora a la categoria d’investigaci\u00f3 precl\u00ednica. Felipe Casanueva, que ha contribu\u00eft a l\u2019augment del coneixement internacional en el camp de l’obesitat, ha estat mereixedor del premi en la categoria cl\u00ednica.<\/p>\n

L’acte acad\u00e8mic de lliurament dels premis 2012 de la Fundaci\u00f3 Lilly a la investigaci\u00f3 biom\u00e8dica, que va tenir lloc el passat 28 de juny a Madrid, va estar presidit per la ministra de Sanitat, Ana Mato, i pel conseller Honor\u00edfic de la Fundaci\u00f3 Lilly, Jos\u00e9 Antonio Guti\u00e9rrez. A m\u00e9s, tamb\u00e9 van intervenir Carmen Vela, Secret\u00e0ria d’Estat d’Investigaci\u00f3, Emilio Lora-Tamayo, president del Consell Superior d’Investigacions Cient\u00edfiques (CSIC) i Javier Ellena, President de la Fundaci\u00f3 Lilly.<\/p>\n

Recerca precl\u00ednica premiada: VPH i c\u00e0ncer<\/span>
\n<\/strong> El c\u00e0ncer d’\u00fater o c\u00e8rvix afecta a prop de dos milions de dones a Espanya. En la majoria dels casos, els causants directes s\u00f3n certs subtipus del virus del papil\u00b7loma hum\u00e0 (VPH). A m\u00e9s, es calcula que aquesta fam\u00edlia viral \u00e9s la responsable del 5% de tots els tumors humans.<\/p>\n

Les vacunes que protegeixen contra el VPH ofereixen un elevat rang d’efectivitat, d’entre el 70 i el 90%. L’investigador F. Xavier Bosch, cap del grup de recerca de Virus i C\u00e0ncer de l\u2019IDIBELL i director del Programa de Recerca en Epidemiologia del C\u00e0ncer de l’Institut Catal\u00e0 d\u2019Oncologia (ICO), considera \u201ctota una fita de la ci\u00e8ncia la possibilitat d’impedir el desenvolupament d’una malaltia, en aquest cas un c\u00e0ncer, amb vacunes\u201d.<\/p>\n

Concretament, es pret\u00e9n continuar amb la recerca sobre la import\u00e0ncia dels subtipus del VPH en el c\u00e0ncer de cap i coll d\u2019\u00fater. Es valorar\u00e0 la situaci\u00f3 a nivell internacional, especialment en pa\u00efsos com l’\u00cdndia on aquesta patologia \u00e9s una de les m\u00e9s freq\u00fcents entre els homes. Per aix\u00f2, el grup de recerca del Dr. Bosch emprar\u00e0 noves tecnologies per explorar la influ\u00e8ncia d’altres tipus de papil\u00b7loma. El premi, dotat amb 140.000 euros, aniran destinats a l’estudi del VPH i a l’elaboraci\u00f3 d’indicadors que permetin identificar, planificar i implementar estrat\u00e8gies preventives dels c\u00e0ncers associats a aquests virus. “Estudiarem si els papil\u00b7lomes que presenten trofisme cutani poden tenir alguna implicaci\u00f3 en el c\u00e0ncer de vulva o de cavitat oral”, declara el Dr Bosch.<\/p>\n

Vacuna contra el VPH<\/strong>
\n<\/strong> El proper any l’equip de Bosch t\u00e9 previst acabar altres assajos, actualment en fase III, amb la segona generaci\u00f3 de vacunes per al VPH que inclouria nou tipus virals. Actualment, les vacunes disponibles tenen entre dos i quatre tipus virals. Es planteja a m\u00e9s estudiar aquesta nova vacuna, sota un protocol que Bosch ha plantejat a la Uni\u00f3 Europea, amb l’objectiu de reduir el c\u00e0ncer de c\u00e8rvix o dels associats al VPH ampliant l’espectre de vacunaci\u00f3 als 26 o 30 anys. “Les dones sexualment actives es vacunaran, vigilant que no estiguin infectades. Les no infectades que es vacunin tindran un risc baix\u00edssim de patir la malaltia i s’allargar\u00e0 el seu programa de cribratge. En el cas de no infecci\u00f3, se sotmetran a protocols de diagn\u00f2stic i ter\u00e0pia si cal”, conclou Bosch.<\/p>\n","protected":false},"excerpt":{"rendered":"

Acte de lliurament dels premis Fundaci\u00f3 Lilly d’Investigaci\u00f3 Biom\u00e8dica Xavier Bosch, investigador de l’IDIBELL a l’ICO i referent mundial en virus del papil\u00b7loma hum\u00e0 i c\u00e0ncer de c\u00e8rvix, ha rebut el premi 2012 de la Fundaci\u00f3 Lilly en reconeixement a la innovaci\u00f3 investigadora a la categoria d’investigaci\u00f3 precl\u00ednica. Felipe Casanueva, que ha contribu\u00eft a l\u2019augment […]<\/p>\n","protected":false},"author":6,"featured_media":21624,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[332,337,454],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-10 11:29:04","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9494"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=9494"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9494\/revisions"}],"predecessor-version":[{"id":21625,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9494\/revisions\/21625"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/21624"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=9494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=9494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=9494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}